Syapse Receives $25,000,000 Series C Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6884d3e3-0db3-4b0e-aa1d-d0fb9df9a947 - Date
1/12/2016 - Company Name
Syapse - Mailing Address
101 University Ave. Palo Alto, CA 94301 USA - Company Description
Built on a powerful cloud-based semantic data platform, Syapse applications enable the generation and use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. - Website
http://www.syapse.com - Transaction Type
Venture Equity - Transaction Amount
$25,000,000 - Transaction Round
Series C - Proceeds Purposes
Syapse has built a market-leading position in the clinical implementation of precision medicine for oncology and will use this funding round to drive the rapid expansion of its category-defining software, Syapse Precision Medicine Platform, in community health systems. - M&A Terms
- Venture Investor
Ascension Ventures - Venture Investor
The Social+Capital Partnership - Venture Investor
Safeguard Scientifics
